JPH0759501B2 - ペレツト製剤 - Google Patents

ペレツト製剤

Info

Publication number
JPH0759501B2
JPH0759501B2 JP60190021A JP19002185A JPH0759501B2 JP H0759501 B2 JPH0759501 B2 JP H0759501B2 JP 60190021 A JP60190021 A JP 60190021A JP 19002185 A JP19002185 A JP 19002185A JP H0759501 B2 JPH0759501 B2 JP H0759501B2
Authority
JP
Japan
Prior art keywords
sustained
acemethacin
release preparation
pellet
relatively high
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60190021A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6165817A (ja
Inventor
ハンス‐デイーター・デル
ラインホルト・クラウス
デトレフ・シールステツト
Original Assignee
トロポンベルケ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・カンパニー・コマンジツト・ゲゼルシヤフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by トロポンベルケ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・カンパニー・コマンジツト・ゲゼルシヤフト filed Critical トロポンベルケ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・カンパニー・コマンジツト・ゲゼルシヤフト
Publication of JPS6165817A publication Critical patent/JPS6165817A/ja
Publication of JPH0759501B2 publication Critical patent/JPH0759501B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP60190021A 1984-08-30 1985-08-30 ペレツト製剤 Expired - Lifetime JPH0759501B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843431861 DE3431861A1 (de) 1984-08-30 1984-08-30 Pellet-zubereitung
DE3431861.5 1984-08-30

Publications (2)

Publication Number Publication Date
JPS6165817A JPS6165817A (ja) 1986-04-04
JPH0759501B2 true JPH0759501B2 (ja) 1995-06-28

Family

ID=6244255

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60190021A Expired - Lifetime JPH0759501B2 (ja) 1984-08-30 1985-08-30 ペレツト製剤

Country Status (16)

Country Link
US (1) US4900557A (show.php)
EP (1) EP0173210B1 (show.php)
JP (1) JPH0759501B2 (show.php)
KR (1) KR860001591A (show.php)
AT (1) ATE52688T1 (show.php)
AU (1) AU4657085A (show.php)
CA (1) CA1255223A (show.php)
DE (2) DE3431861A1 (show.php)
DK (1) DK163208C (show.php)
FI (1) FI853296L (show.php)
GR (1) GR852101B (show.php)
HU (1) HUT39607A (show.php)
IL (1) IL76201A0 (show.php)
NO (1) NO853249L (show.php)
PT (1) PT81039B (show.php)
ZA (1) ZA856597B (show.php)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265061B1 (en) * 1986-09-18 1992-01-08 London School of Pharmacy Innovations Ltd Pharmaceutical formulation
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
JPH06508371A (ja) 1991-06-21 1994-09-22 ユニバーシティー オブ シンシナティ 経口投与できる治療用タンパク質及びその製法
IT1251153B (it) * 1991-08-06 1995-05-04 Vectorpharma Int Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
DK0603992T4 (da) * 1992-12-22 2001-03-05 Univ Cincinnati Oral indgivelse af immunologisk aktive biomolekyler og andre terapeutiske proteiner
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
AU783656B2 (en) 1999-09-02 2005-11-24 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
EP1339395A2 (en) 2000-11-28 2003-09-03 Fmc Corporation Edible pga (propylene glycol alginate) coating composition
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
CA2529984C (en) * 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
CN100336501C (zh) * 2003-08-06 2007-09-12 健乔信元医药生技股份有限公司 醋炎痛缓释性圆粒组成物及制备方法
EP1753405A4 (en) * 2004-06-10 2008-09-17 Glatt Air Tech Inc SLOW RELEASE PHARMACEUTICAL PREPARATION
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
BRPI0611342A2 (pt) 2005-04-29 2010-08-31 Tendix Dev Llc motor de combustão interna
US20080213339A1 (en) * 2005-08-02 2008-09-04 Roger Imboden Pharmaceutical Composition Containing Indometacin and/or Acemetacin
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN104825397A (zh) * 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
WO2019199246A1 (en) 2018-04-13 2019-10-17 Santa Farma İlaç Sanayi̇ A.Ş. A sustained release formulation comprising acemetacin with bimodal in vitro release
JP7125791B2 (ja) 2018-05-23 2022-08-25 シャンハイ ダブリュディー ファーマシューティカル カンパニー，リミティド 活性薬物成分の放出制御システムおよびその製造方法
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
EP3796904B1 (en) 2018-11-16 2023-01-25 Santa Farma Ilaç Sanayi A.S. Sustained release acemetacin compositions
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193985A (en) 1977-03-30 1980-03-18 A/S Alfred Benzon Multiple-units drug dose

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801203A (en) * 1951-03-22 1957-07-30 Byk Gulden Lomberg Chem Fab X-ray method of digestive enzyme diagnosis using protected core of contrast agent
IT628280A (show.php) * 1956-11-05
US3017329A (en) * 1957-08-15 1962-01-16 Dow Chemical Co Method of locating enteric constrictions with a plurality of pills containing an x-ray contrast agent
US3065142A (en) * 1958-07-30 1962-11-20 Armour Pharma Gastric resistant medicinal preparation
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
JPS54138128A (en) * 1978-04-19 1979-10-26 Akiyama Jiyouzai Kk Double contrast medium for intestine
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH04225410A (ja) * 1990-12-27 1992-08-14 Hitachi Ltd 文書編集装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193985A (en) 1977-03-30 1980-03-18 A/S Alfred Benzon Multiple-units drug dose

Also Published As

Publication number Publication date
PT81039A (en) 1985-09-01
DE3577654D1 (de) 1990-06-21
EP0173210B1 (de) 1990-05-16
HUT39607A (en) 1986-10-29
DE3431861A1 (de) 1986-03-13
CA1255223A (en) 1989-06-06
FI853296A7 (fi) 1986-03-01
EP0173210A2 (de) 1986-03-05
EP0173210A3 (en) 1987-05-13
FI853296L (fi) 1986-03-01
PT81039B (pt) 1987-12-30
DK163208B (da) 1992-02-10
US4900557A (en) 1990-02-13
ZA856597B (en) 1986-04-30
FI853296A0 (fi) 1985-08-28
ATE52688T1 (de) 1990-06-15
JPS6165817A (ja) 1986-04-04
AU4657085A (en) 1986-03-06
DK394685D0 (da) 1985-08-29
KR860001591A (ko) 1986-03-20
DK394685A (da) 1986-03-01
IL76201A0 (en) 1985-12-31
GR852101B (show.php) 1986-01-02
DK163208C (da) 1992-06-29
NO853249L (no) 1986-03-03

Similar Documents

Publication Publication Date Title
JPH0759501B2 (ja) ペレツト製剤
JP2720932B2 (ja) 経口投与用アセトアミノフエン錠剤の製造法及びアセトアミノフエン二層錠剤
JP5752227B2 (ja) 口腔内崩壊錠
KR101141508B1 (ko) 판토프라졸 복합 미립자 제형
EP1324752B1 (en) Delayed release pharmaceutical formulations
JPH0251402B2 (show.php)
JPH0122245B2 (show.php)
AU2004305226A1 (en) Method for the production of a solid, orally applicable pharmaceutical composition
JP2000281564A (ja) 医薬製剤
DK162375B (da) Lagerstabile hurtig-desintegrerende komprimerede laegemiddelpraeparater samt fremgangsmaade til fremstilling heraf
JP2556623B2 (ja) 高いイブプロフェン含有量を示す顆粒状物
WO1999016448A1 (fr) Comprime de theophylline a liberation prolongee
CN101312716A (zh) 具有速释和/或控释特征的药物剂型
EA028217B1 (ru) Разрушающаяся во рту таблетка (варианты)
CA2435714C (en) Fenofibrate tablets
JP2003055199A (ja) 徐放性マイクロペレット
JP4705747B2 (ja) 薬剤組成物
JP3929522B2 (ja) 難水溶性薬物の徐放性製剤
WO2002034268A1 (en) Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2-[2-[4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient
WO2022072099A9 (en) Immediate release dosage forms, methods of making and using
WO2001070221A1 (en) Sustained release oral preparations
JPH0130A (ja) 徐放性製剤
JP2005519097A (ja) 医薬組成物
CA2632039A1 (en) Bursting pellets
NZ718686A (en) Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof